TITLE

At-the-Market Financing Facility Secures ISCO $25M

PUB. DATE
December 2010
SOURCE
Bioworld Week;12/20/2010, Vol. 18 Issue 51, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that Apsire Capital Fund LLC agreed to purchase 333,333 shares from International Stem Cell Corp. (ISCO) and is granted a financing facility which allows Aspire to purchase up to 25 million dollars in equity capital over the next three years at ISCO's discretion.
ACCESSION #
56681362

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics